Trial intelligence / Profile preview

Early intervention of Lianhua Qingwen granules for acute pharyngitis

ChiCTR2400085492Phase 4Not yet recruiting

Sponsor
Shandong Second Provincial General Hospital
Start
Jun 2024
Countries
1
01

Overview

Phase 4, randomised trial of Lianhua Qingwen in acute pharyngitis (2 arms), sponsored by Shandong Second Provincial General Hospital. Primary endpoint: Recovery rate of acute pharyngitis. Planned start Jun 2024; status: not yet recruiting.

02

Drugs

Lianhua Qingwen
03

Conditions

acute pharyngitis

Beyond the preview

Go deeper on ChiCTR2400085492.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400085492.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call